We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cytokinetics Announces Presentation of Data From a Phase IIa Clinical Trial of CK-2017357 in Patients With ALS at the 63rd Annual Meeting of the American Academy of Neurology

Product News   Apr 19, 2011

 
Cytokinetics Announces Presentation of Data From a Phase IIa Clinical Trial of CK-2017357 in Patients With ALS at the 63rd Annual Meeting of the American Academy of Neurology
 
 
FURTHER INFORMATION
 
 
 

Related Product News


Embedded Chondroitinase ABC Shows Promise for Spinal Injury Treatment

Product News

Recent publication shows the therapeutic efficacy of microtube-embedded Chondroitinase ABC on a group of dogs with naturally occurring spinal injuries.

READ MORE

GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment

Product News

Artificial Intelligence (AI)-powered applications will help predict how individual patients will respond to immunotherapies in advance of treatment.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE